 |
|
New analysis says eradicating polio a better option than extended control of the disease
April 12, 2007Boston, MA — Concerns about the high perceived costs of eradicating the relatively low number of polio cases worldwide have led to recent suggestions that it is time to shift from a goal of eradication to control—abandoning eradication and allowing wild poliovirus to continue to circulate, which proponents of control believe can sustain the low number of cases. In a new study, researchers from the Harvard School of Public Health (HSPH) analyzed the costs and health outcomes of control and eradication options. They found that the relatively high short-term costs of global polio eradication will ultimately be much lower than the long-term financial and human health costs required to control polio forever. The study appears online April 11 and in the April 21, 2007 print issue of The Lancet.
Poliomyelitis, which mainly affects children, is a highly infectious viral disease that can cause inflammation of motor neurons of the brainstem and spinal cord and lead to paralysis. Although successfully eliminated in the U.S. and most of the world through the use of poliovirus vaccines, endemic wild polioviruses still continue to circulate in some countries (notably in parts of India, Nigeria, Pakistan and Afghanistan). Since 1988, the Global Polio Eradication Initiative has reduced the global incidence of poliomyelitis by 99%, at a cost of more than $4 billion.
Kimberly Thompson, Associate Professor of Risk Analysis and Decision Science at HSPH, and Radboud Duintjer Tebbens, a research associate at HSPH, used a mathematical model to demonstrate the importance of maintaining and increasing the immunization intensity in currently endemic areas. Immunization intensity is an indication of the level of vaccination effort aimed at increasing population immunity. The authors suggest that even a relatively small decrease in intensity of immunization could lead to relatively large outbreaks. They emphasized that the world cannot let up in its vaccination efforts for polio, at least until eradication has been achieved.
Comparing the numbers of expected cases and costs for 20 years into the future for a range of eradication and control options, the authors found that eradication is the best solution. For example, a control policy that relied only on routine immunization could lead to approximately 200,000 expected paralytic polio cases every year in low-income countries. "As long as it is technically achievable, eradication offers both lower cumulative costs and cases than control in the long-term, even with the costs of achieving eradication exceeding several billion dollars more," said Thompson.
The authors note in the study that debate about eradication versus control should include careful consideration of the trade-offs of the options. "Control means high costs and low cases forever or low costs and high cases forever, but not low costs and low cases forever, which is only an option if we continue to pay high costs in the short-term until we eradicate," said Thompson.
Although the price tag of potentially additional billions of dollars to eradicate polio may sound high, the study reports that paying now is the best way to keep the overall costs as low as possible. "A wavering commitment to eradication is not a good option," said Duintjer Tebbens.
Harvard School of Public Health
Comparing the numbers of expected cases and costs for 20 years into the future for a range of eradication and control options, the authors found that eradication is the best solution. For example, a control policy that relied only on routine immunization could lead to approximately 200,000 expected paralytic polio cases every year in low-income countries. "As long as it is technically achievable, eradication offers both lower cumulative costs and cases than control in the long-term, even with the costs of achieving eradication exceeding several billion dollars more," said Thompson.
The authors note in the study that debate about eradication versus control should include careful consideration of the trade-offs of the options. "Control means high costs and low cases forever or low costs and high cases forever, but not low costs and low cases forever, which is only an option if we continue to pay high costs in the short-term until we eradicate," said Thompson.
Although the price tag of potentially additional billions of dollars to eradicate polio may sound high, the study reports that paying now is the best way to keep the overall costs as low as possible. "A wavering commitment to eradication is not a good option," said Duintjer Tebbens.
Harvard School of Public Health
Science News and Science Current Events Tag Cloud
This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size.
Stress Flu Vaccine Liquid Crystal Space Exploration Gene Mutation Whales Sinkhole Cortisol Fatigue Bioenergy Postmenopausal Hurricanes Acupuncture Insulin Virtual Reality Tanning Galaxy Formation Cocaine Addiction Cannabinoids Cleft Palate Ethanol Morphine Gamma-ray Neurogenesis Prostate Cancer
See More: Science News Tags
Polio Current Events and Polio News RSSParents of internationally adopted children advised to verify children's immunization levels
A study by the division of global child health at Case Western Reserve University School of Medicine cautions adoptive parents not to rely solely on vaccination records when gauging their internationally adopted children's immunizations.
Virginia Tech virologist developing more potent vaccine technology
Virginia Tech virologist Chris Roberts' goal is to develop a platform for a flu vaccine that allows rapid modifications to meet new strains of flu.
Catching the common cold virus: BYU researchers coming down with the rhinovirus genome
A new study by Brigham Young University researchers on the virus behind nearly half of all cold infections explains how and where evolution occurs in the rhinovirus genome and what this means for possible vaccines.
Mathematical models of adaptive immunity
More than five million people die every year from infectious diseases, despite the availability of numerous antibiotics and vaccines.
First Holistic Guide to Primate Disease Covers Critical Gap in Global Health
Why are so many infectious diseases jumping from animals to humans? Why do we have so little capacity to predict epidemics, or avoid them?
Most vaccine-allergic children can still be safely vaccinated, Hopkins experts say
With close monitoring and a few standard precautions, nearly all children with known or suspected vaccine allergies can be safely immunized, according to a team of vaccine safety experts led by the Johns Hopkins Children's Center.
Parents follow pediatrician advice on administering MMR vaccinations
News stories about an allegedly harmful link between the mumps, measles and rubella vaccine and the onset of autism had little effect on whether U.S. parents immunized their children, according to a review of immunization records and news stories. Parents' decisions were more likely influenced by recommendations from their child's pediatrician, the researchers said.
Combination vaccine protects monkeys from ebola and Marburg viruses
An experimental, combination vaccine against Ebola and Marburg viruses using virus-like particles (VLPs) provides complete protection against infection in monkeys.
Cleaner water through nanotechnology
Tiny particles of pure silica coated with an active material could be used to remove toxic chemicals, bacteria, viruses, and other hazardous materials from water much more effectively and at lower cost than conventional water purification methods, according to researchers writing in the current issue of the International Journal of Nanotechnology.
Cell death suppression increases efficacy of M2 vaccines
Significant public attention has recently been focused on the development of new anti-influenza (flu) vaccines that provide protection against a broad spectrum of viral strains. One proposed strategy is to utilize conserved viral protein, M2. Clinical trials of M2-containing influenza vaccines were recently initiated by US and European companies.
More Polio Current Events and Polio News Articles
 |
Polio: An American Story by David M. Oshinsky (Author) Here David Oshinsky tells the gripping story of the polio terror and of the intense effort to find a cure, from the March of Dimes to the discovery of the Salk and Sabin vaccines--and beyond. Drawing on newly available papers of Jonas Salk, Albert Sabin and other key players, Oshinsky paints a suspenseful portrait of the race for the cure, weaving a dramatic tale centered on the furious rivalry between Salk and Sabin. He also tells the story of Isabel Morgan, perhaps the most talented of all polio researchers, who might have beaten Salk to the prize if she had not retired to raise a family. Oshinsky offers an insightful look at the National Foundation for Infantile Paralysis, which was founded in the 1930s by FDR and Basil O'Connor, it revolutionized fundraising and the perception... |
 |
American Experience: The Polio Crusade Based in part on David Oshinsky's Pulitzer Prize-winning book, Polio: An American Story, this one-hour film chronicles a decades-long crusade, fueled by the bold leadership of a single philanthropy and its innovative public relations campaign, and features a bitter battle between two scientists and the breakthrough of a forgotten woman researcher. |
 |
Small Steps: The Year I Got Polio by Peg Kehret (Author) Ten years ago, In a riveting story of courage and hope, Peg Kehret wrote of months spent in a hospital when she was twelve, first struggling to survive a severe case of polio, then slowly learning to walk again. The book deeply touched readers of all ages and received many awards and honors. This anniversary edition includes an updated and extended epilogue about the author's experiences since the original publication. It also includes twelve pages of new photos and a lengthy section about polio, past and present. This 10th Anniversary Edition will inspire a whole new generation of readers. Those readers who already love it will find themselves reaching for it one more time. |
 |
A Paralyzing Fear Starring: Olympia Dukakis Directed By: Nina Gilden Seavey {Emmy Award Winner!} {Erik Barnouw Prize for Best Historical Film of the Year} {Golden Apple Award, National Education Media Network} {Golden Hugo Award, International Film & Video Communications} {International Monitor Award, International Tele Production Society} {Peer Award, Washington Film and Video Council} Seldom has society come full circle in the cycle of a disease-- from illness, to epidemic, to cure. Polio is the 20th century's most notable exception. First appearing in the United States in 1916, the disease crippled tens of thousands of children every summer until it was finally eradicated by the Salk vaccine beginning in 1954. Every baby boomer remembers the terror of the polio epidemic and the thrill when the vaccine was discovered. A... |
 |
The Polio Paradox: Understanding and Treating "Post-Polio Syndrome" and Chronic Fatigue by Richard L. Bruno (Author) Polio is a disease of paradoxes, the major one being that although the threat of the 'dreaded disease' ended with the Salk vaccine in 1954, many polio survivors are now experiencing the onset of 'Post-Polio Syndrome' (PPS), new but related symptoms which may include chronic fatigue, muscle weakness, intolerance to cold, and more. In his groundbreaking book, Dr. Bruno has sounded an alarming wake-up call for both doctors and PPS sufferers, including a large number who were originally misdiagnosed with something other than polio and can now pursue the medical help they need. By revealing how the treatment of polio in the past has exacerbated what we now call PPS today, THEPOLIO PARADOX provides hope and new treatment information for an entire generation. |
 |
Polio: An American Story by Oxford University Press, USA All who lived in the early 1950s remember the fear of polio and the elation felt when a successful vaccine was found. Now David Oshinsky tells the gripping story of the polio terror and of the intense effort to find a cure, from the March of Dimes to the discovery of the Salk and Sabin vaccines--and beyond. Here is a remarkable portrait of America in the early 1950s, using the widespread panic over polio to shed light on our national obsessions and fears. Drawing on newly available papers of Jonas Salk, Albert Sabin and other key players, Oshinsky paints a suspenseful portrait of the race for the cure, weaving a dramatic tale centered on the furious rivalry between Salk and Sabin. Indeed, the competition was marked by a deep-seated ill will among the researchers that remained with them... |
 |
In the Shadow of Polio: A Personal and Social History by Kathryn Black (Author) In 1954 Kathryn Black’s mother became one of the millions of people worldwide stricken with polio. A year later, as the Salk vaccine became widely available, the nation heaved a collective sigh of relief, and promptly buried its memories along with its dead.In the Shadow of Polio offers a penetrating look at this intense and significant period in American history. Black explores the lethal progression of her mother’s illness and its devastating emotional impact upon her family, interweaving her story with chapters that broaden into the social and historical context of the epidemic that randomly swept the nation in the 1940s and 1950s. Rich with anecdotes from Black’s years of interviews and correspondence, In the Shadow of Polio is a journey into the homes and hospitals, the lives... |
 |
In Search of the Polio Vaccine (History Channel) (A&E DVD Archives) Starring: Artist Not Provided |
 |
The Polio Paradox: What You Need to Know by Richard L. Bruno (Author) Polio is a disease of paradoxes, the major one being that although the threat of the "dreaded disease" ended with the Salk vaccine in 1954, many polio survivors are now experiencing the onset of Post-Polio Syndrome (PPS), new but related symptoms which may include chronic fatigue, muscle weakness, intolerance to cold, joint pain, and more. In his groundbreaking book, Dr. Bruno has sounded an alarming wake-up call for both doctors and PPS sufferers, including a large number who were originally misdiagnosed with something other than polio and can now pursue the medical help they need. By revealing how the physical and emotional treatment of polio in the past has exacerbated what we now call PPS today, THE POLIO PARADOX provides hope in the form of understanding and new treatment information... |
 |
POLIO (POLIOVIRUS) GIANT MICROBE PLUSH by Giant Microbes GIANTmicrobes are fun and educational?a great way to learn about various health topics and the microscopic critters that are found in and around us. Each microbe character is 5-7? in size--over a million times their actual size! Perfect for teachers, parents and budding scientists?they also make humorous gifts. Each microbe comes with an information tag including scientific name, an image of the actual microbe, and a mini history and science lesson. Not suitable for children under 3 years. Our products are made by top manufacturers who care about toy safety, quality and value. Your order will ship factory fresh directly from our warehouse to your door. We carefully inspect and beautifully package every order before shipment to ensure that you receive high quality products that are... |
| © 2009 BrightSurf.com |